Yuko Y. Palesch

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Biostatistics Biology
Google:
"Yuko Palesch"

Children

Sign in to add trainee
Valerie L. Durkalski grad student 2001 MUSC
Renee L. Hebert grad student 2001 MUSC
Amy S. Nowacki grad student 2008 MUSC
Jordan J. Elm grad student 2009 MUSC
Yanqiu Weng grad student 2013 MUSC
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fukuda-Doi M, Yamamoto H, Koga M, et al. (2020) Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Stroke. STROKEAHA120029770
Okazaki S, Yamamoto H, Foster LD, et al. (2020) Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 Trial. Cerebrovascular Diseases (Basel, Switzerland). 1-6
Chalos V, van der Ende NAM, Lingsma HF, et al. (2019) National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke. Stroke. STROKEAHA119026791
Farrant M, Easton JD, Adelman EE, et al. (2019) Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. Jama Network Open. 2: e1910769
Moullaali TJ, Wang X, Martin RH, et al. (2019) Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. The Lancet. Neurology. 18: 857-864
Johnston SC, Elm JJ, Easton JD, et al. (2019) Time Course for Benefit and Risk of Clopidogrel and Aspirin after Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial. Circulation
Tillman H, Johnston SC, Farrant M, et al. (2019) Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. Jama Neurology
Selim M, Foster LD, Moy CS, et al. (2019) Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. The Lancet. Neurology
Frankel M, Fan L, Yeatts SD, et al. (2019) The Association of Very Early Serum levels of S100B, GFAP, UCH-L1, and SBDP with Outcome in ProTECT III. Journal of Neurotrauma
Toyoda K, Koga M, Yamamoto H, et al. (2018) Clinical outcomes depending on acute blood pressure after cerebral hemorrhage. Annals of Neurology
See more...